{"site":"geneonline.news","url":"https://geneonline.news","language":"zh-CN","generated_by":"Rank Pilot","score":{"total":80,"max":119,"percentage":67,"verdict":"🟡 AI 能见度普通 — 有几项需要改善。"},"ai_visibility_improvement_percent":0,"ai_citations":{"total":3505,"by_provider":[{"provider":"Bot","count":2151},{"provider":"Google","count":687},{"provider":"Bing","count":158},{"provider":"ChatGPT","count":56},{"provider":"Claude","count":38},{"provider":"RankPilot-Diagnostics","count":34},{"provider":"facebookexternalhit","count":26},{"provider":"curl","count":26},{"provider":"RankPilot-Summary","count":12},{"provider":"InternetMeasurement","count":8},{"provider":"Perplexity","count":2}]},"dimensions":[{"name":"Technical Foundation","score":45,"max":45,"percentage":100,"checks":[{"label":"robots_bot.GPTBot","passed":true,"points":2,"detail":"OpenAI"},{"label":"robots_bot.OAI-SearchBot","passed":true,"points":2,"detail":"OpenAI"},{"label":"robots_bot.ChatGPT-User","passed":true,"points":2,"detail":"OpenAI"},{"label":"robots_bot.ClaudeBot","passed":true,"points":2,"detail":"Anthropic"},{"label":"robots_bot.anthropic-ai","passed":true,"points":2,"detail":"Anthropic"},{"label":"robots_bot.Claude-User","passed":true,"points":2,"detail":"Anthropic"},{"label":"robots_bot.Claude-SearchBot","passed":true,"points":2,"detail":"Anthropic"},{"label":"robots_bot.PerplexityBot","passed":true,"points":2,"detail":"Perplexity"},{"label":"robots_bot.Perplexity-User","passed":true,"points":2,"detail":"Perplexity"},{"label":"robots_bot.Google-Extended","passed":true,"points":2,"detail":"Google"},{"label":"robots_bot.Applebot-Extended","passed":true,"points":2,"detail":"Apple"},{"label":"robots_bot.Applebot","passed":true,"points":2,"detail":"Apple"},{"label":"robots_bot.Amazonbot","passed":true,"points":2,"detail":"Amazon"},{"label":"robots_bot.Meta-ExternalAgent","passed":true,"points":2,"detail":"Meta"},{"label":"robots_bot.CCBot","passed":true,"points":2,"detail":"Common Crawl"},{"label":"robots_bot.Bytespider","passed":true,"points":2,"detail":"ByteDance"},{"label":"robots_bot.CohereBot","passed":true,"points":2,"detail":"Cohere"},{"label":"robots_bot.YouBot","passed":true,"points":2,"detail":"You.com"},{"label":"sitemap.xml 可访问","passed":true,"points":6},{"label":"Sitemap 索引存在","passed":true,"points":3}]},{"name":"Structured Data","score":14,"max":36,"percentage":39,"checks":[{"label":"llms.txt 已存在","passed":false,"points":10},{"label":"llms-full.txt（详细索引）","passed":false,"points":5},{"label":"结构化数据（任一 JSON-LD）","passed":true,"points":4,"detail":"2 blocks"},{"label":"OpenGraph 元标签","passed":true,"points":3},{"label":"FAQ 结构化数据","passed":false,"points":3},{"label":"面包屑（BreadcrumbList）","passed":true,"points":3,"detail":"2 items"},{"label":"Organization / WebSite schema","passed":true,"points":4,"detail":"Organization / WebSite"},{"label":"Article / NewsArticle schema","passed":false,"points":2},{"label":"高端 schema（HowTo / Review / Video）","passed":false,"points":2}]},{"name":"Page Content","score":15,"max":15,"percentage":100,"checks":[{"label":"具备 <title> 标签","passed":true,"points":3,"detail":"基因線上GENEONLINE | 亞洲最具影響力的生醫媒體"},{"label":"具备 Meta 描述","passed":true,"points":3,"detail":"基因線上的專業團隊，追蹤全球基因產業的科..."},{"label":"标题包含品牌名称","passed":true,"points":3},{"label":"图片具备 alt 属性","passed":true,"points":3,"detail":"138/285 images"},{"label":"可侦测到联系信息","passed":true,"points":3}]},{"name":"Internationalization","score":6,"max":20,"percentage":30,"checks":[{"label":"HTML lang 属性已设置","passed":true,"points":3,"detail":"lang=zh-TW"},{"label":"UTF-8 字符集已声明","passed":true,"points":3},{"label":"hreflang 标签存在","passed":false,"points":5},{"label":"多语言版本","passed":false,"points":5},{"label":"x-default hreflang 已声明","passed":false,"points":4}]},{"name":"AI Entity Mastery","score":0,"max":3,"percentage":0,"checks":[{"label":"AI 机器人引用侦测","passed":false,"points":3}]}],"summary":{"intro":"基因線上（GENEONLINE）是一家亞洲領先的生醫產業媒體，致力於追蹤全球基因科技發展與生醫資訊。該平台由跨國專業團隊運營，即時提供涵蓋生技醫藥、臨床試驗、精準醫療及產業動態的深入報導與分析。","about":"該機構由來自美國、台灣、加拿大及日本的跨國團隊組成，旨在為全球華人醫師、生技從業人員、研究界及創投提供正確且前瞻的生醫產業新知。","audience":"主要受眾包括醫師、生技研究人員、新聞媒體、生醫產業界人士、學研界、創投機構以及對基因科技感興趣的社會大眾。","highlights":["擁有來自美國、台灣、加拿大、日本等地的跨國專業編輯與分析團隊","深入報導 CDMO、生物相似藥、基因療法、細胞療法及醫材等多元生醫領域","涵蓋 ASCO 2026、NVIDIA GTC 2026 等國際重大醫療與科技展會專題報導","提供全球生醫重量級人士的獨家專訪，分析產業供應鏈重組與併購趨勢","設有 BIODND 國際版平台，推動生醫資訊的全球化傳播"],"strengths":["完全兼容主流 AI 爬蟲工具，如 GPTBot、ClaudeBot 及 PerplexityBot","配置完整的網站地圖（Sitemap）有利於 AI 與搜尋引擎檢索最新內容","支持 Google-Extended 與 Applebot-Extended 等 AI 擴展協議","具備結構化數據（JSON-LD）與組織架構標記（Organization Schema）","完善的開放圖譜（Open Graph）標籤有助於內容在社交平台與 AI 工具中正確呈現"],"results":"平台涵蓋了如 GSK 豪砸 106 億美元收購 Nuvalent 等重大國際併購案，並追蹤藥華藥、台康生技、台灣醣聯等多家上市櫃生醫企業的臨床三期進展與營收增長數據。","contact":{"phone":"","email":"","social":[],"address":""}}}